N/A
N=23
In Vivo Three-Dimensional Determination of Osteoarthritis Brace Effectiveness
Osteoarthritis, Knee
Bottom Line
View on ClinicalTrials.gov: NCT04111276 ↗Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Oct 2021
Primary outcome: Primary: Medial Condylar Separation With Brace — 0.60 mm
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Breg Osteoarthritis Brace gait fluoroscopy (Device); Gait fluoroscopy without brace (Other); JointVue ultrasound (Diagnostic_test); Computer Tomography (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- The University of Tennessee, Knoxville
- Primary completion
- Nov 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medial Condylar Separation With Brace |
0.60 | — |
| PRIMARY Medial Condylar Separation Without Brace |
-1.05 | — |
Summary
In vivo knee kinematics will be assessed for 20 subjects that have been clinically diagnosed with substantial unicompartmental osteoarthritis (OA) by one of the surgeons of Colorado Joint Replacement; this is the location from which participants will be recruited. The objective of this study will be to analyze subjects with symptomatic unicompartmental osteoarthritis under in vivo dynamic, weight-bearing conditions using video fluoroscopy to determine if present-day OA knee braces provide separation of the femoral condyle from the tibial plateau, thus avoiding excessive loads on the degenerative compartment.
Eligibility Criteria
Inclusion Criteria
- Must be a patient of Colorado Joint Replacement.
- Must be diagnosed with marked unicompartimental degenerative joint space narrowing.
- Bilateral subjects may not be included in the subject population
Exclusion Criteria
- Pregnant, potentially pregnant or lactating females. To satisfy radiation protocol, each female subject will be asked if she is pregnant, or possibly could be pregnant. A pregnant person will not be allowed to participate in the study.
- Subjects who are unable to perform normal walking.
- Subjects who are unwilling to sign Informed Consent/ HIPAA documents.
- Does not speak English.
Data sourced from ClinicalTrials.gov (NCT04111276). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.